Find results that contain all of your keywords. Content filter is on. Search will return best illustrations, stock vectors and clipart.
Make it so!
You have chosen to exclude "" from your results.

Choose orientation:
Related commercial searches:

car

cell

interacting

cancer

cd19

cd20

antigens

 rituximab monoclonal antibody drug targets lymphocytes indications use indicate rheumatoid arthritis number lymphocyte antigen epitope peptide fragment bound to fab include leukemia theoretical model protein expressed surface cells
Order by: relevancy of keywords | publishing date | most downloaded

Cd20 Cartoons, Illustrations & Vector Stock Images

- 17 images
CAR T cell interacting with a cancer cell through CD19 and CD20 antigens
Rituximab monoclonal antibody drug. Targets CD20 on B-lymphocytes. Indications for use indicate rheumatoid arthritis and a number
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
Ocrelizumab monoclonal antibody drug. Targets CD20 on B-cells and is used in the treatment multiple sclerosis. Generic name and.
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 (theoretical model). Protein expressed on the surface of B-cells. Anti-CD20 monoclonal antibody drugs
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
B-lymphocyte antigen CD20 epitope peptide fragment, bound to rituximab (Fab fragment). Indications for rituximab include leukemia
CAR T cell interacting with a cancer cell through CD19 antigen
OR-gate CAR T cells
OR-gate CAR T cells